| Current Price | $4.23 | Mkt Cap | $746.2M |
|---|---|---|---|
| Open | $4.46 | P/E Ratio | 0.00 |
| Prev. Close | $4.23 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.21 - $4.50 | Volume | 6,064,590 |
| 52-Wk Range | $1.38 - $6.29 | Avg. Daily Vol. | 7,433,851 |
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
| Current Price | $4.23 | Mkt Cap | $746.2M |
|---|---|---|---|
| Open | $4.46 | P/E Ratio | 0.00 |
| Prev. Close | $4.23 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.21 - $4.50 | Volume | 6,064,590 |
| 52-Wk Range | $1.38 - $6.29 | Avg. Daily Vol. | 7,433,851 |
The best Bull and Bear pitches based on recency and number of recommendations.
[blind date]HER: I'm a ghost writerME {trying not to look too scared}: When did you die?
Read the most recent pitches from players about BCRX.
Recs
PensionExtender
(57.34)
Submitted: 6/30/2020 5:50:50 PM :
Start Price:
$4.90
NASDAQ:BCRX Score:
-20.56
COVID-19 biotech should continue to grow with oral delivery system of vaccine
Recs
mdriver78
(72.96)
Submitted: 5/8/2020 1:14:04 PM :
Start Price:
$4.36
NASDAQ:BCRX Score:
-13.04
Expecting positive sales of over $500 on Berotralstat approval. Plus early clinical data supports BCX9930 as oral monotherapy for complement-mediated diseases plus patient dosing underway in galidesivir trial in COVID-19 patients in Brazil. All sounds quite positive and worth a flyer.
Recs
SmartAce
(99.98)
Submitted: 3/5/2020 3:36:13 PM :
Start Price:
$3.84
NASDAQ:BCRX Score:
-1.17
[blind date]
HER: I'm a ghost writer
ME {trying not to look too scared}: When did you die?
Find the members with the highest scoring picks in BCRX.
Chemnerd (51.38) Score: +564.96
The Score Leader is the player with the highest score across all their picks in BCRX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| KeepYourCoolFool | 98.55 | 7/29/2009 |
|
5Y | $10.58 | -60.16% | +239.92% | +300.08 | 0 Comment | |
| DRASH5 | 35.74 | 7/29/2009 |
|
3W | $10.28 | -59.00% | +240.96% | +299.96 | 0 Comment | |
| WeathermanGR13 | 96.77 | 8/17/2009 |
|
5Y | $9.88 | -57.34% | +235.50% | +292.84 | 0 Comment | |
| BASSTRAX | 77.09 | 8/31/2009 |
|
1Y | $12.99 | -67.55% | +225.18% | +292.73 | 0 Comment | |
| SpencerHar | < 20 | 8/3/2009 |
|
1Y | $9.10 | -53.68% | +232.04% | +285.72 | 0 Comment | |
| BadB0y4Lyfe | 26.24 | 8/10/2009 |
|
5Y | $9.27 | -54.53% | +229.20% | +283.73 | 0 Comment | |
| epc53 | 27.48 | 7/20/2009 |
|
5Y | $6.00 | -29.75% | +250.26% | +280.01 | 0 Comment | |
| clutedog | < 20 | 4/30/2009 |
|
1Y | $3.88 | +8.63% | +279.40% | +270.77 | 1 Comment | |
| 1or5stars | 99.12 | 5/26/2009 |
|
3W | $3.85 | +9.48% | +277.43% | +267.95 | 0 Comment | |
| mathieugp | 25.57 | 10/1/2009 |
|
3W | $8.65 | -51.27% | +213.33% | +264.60 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
